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Abstract 
      A new four derivatives of  2,3-Dihydro-1,4-naphthaquinone were synthesized as possible bioreductive prodrugs for 
5-fluorouracil (5-Fu), Mercaptopurine (6-MP), N-acetyl cysteine (NAC) and 3-bromopyrovic acid (3-BPA) to selectively 
deliver the drugs into the cancer cells and these are:2-((5-fluoro-1,2-dihydropyrimidin-4-yloxy)methyl)-3-hydroxy 
naphthalene-1,4dione(compound A),2-((9H-purin-6-ylthio)-3-hydroxyl naphthalene-1,4dione (compoundB) acetmido-3-((3-
methyl-1,4-dihydro   -naphthalen-2- yl)methylthio)propanoic acid (compound C)andhydroxy-1,4-dioxo-1,4-
dihydronaphthalen-2-yl)methl-3-bromo-2-oxopropanoat       (compound D).Their chemical structures were characterized by 
H
1
 NMR, IR spectroscopy and elemental microanalysis.Thein vitro antitumor activity tests against Hep-2 human larynx    
cancer cell line indicated that compound A,B,C and D have significant anticancer activities when compared with 5-Fu.       
Keywords: Anticancer, proudrug, 2, 3-Dihydro-1, 4-naphthaquinone; bromopyrovic acid, N-acetyl cysteine; 5-
fluorouracil; 6-Mercaptopurine.  
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1. Introduction 
Thiopurines (6-MP)  are used in the maintenance therapy of acute lymphoblastic leukemia and it also displays activity 
against acute and chronic myelogeneousleukemias
(1,2)
. The clinical use of the thiopurines against solid tumors has been 
limited by severe bone marrow toxicity 
(3)
.5-Fu is used for gastrointestinal, pancreas, breast, ovary, and colorectal cancer. 
The use of 5-fluorouracil accompanied by several disadvantages including sever adverse effects, drug resistance, 
limitation of uses, and variable bioavailability
(4)
. (NAC)  is the acetylated derivative of the amino acid L-cysteine 
(5)
.Recently, animal and human studies have shown NAC to be a powerful antioxidant and potential therapeutic agent in 
the treatment of cancer
 (6,7)
.Research has shown NAC to have potential as a chemo preventive agent and as a treatment 
in certain types of cancer
(8)
. Including lung,skin, head and neck, breast, and liver cancer.   In vitro studies have 
demonstrated that NAC to be directly anti-mutagenic and anti-carcinogenic, it is also inhibits the mutagenicity of certain 
compounds in vivo
(9)
. (3-BPA) is a pyruvate-lactate analogue, and strong alkylating agent
(10)
. Recently, it was found to be 
potent inhibitor of glycolysis and oxidative phosphorylation by targeting hexokinase II enzyme (HK II),this enzyme is the 
most important enzyme in the maintaining  the high rate of glycolytic energy production
(11)
.By inhibition this enzyme, ATP 
depletion, and consequently cells death will occur. 3-bromopyruvate (3-BPA) show excellent antitumor activity against 
different types of cancer cells, especially against Hepatocellular carcinoma
(12)
 .One promising aspect for improving the 
distribution of anticancer drugs appears to be the prodrug approach by which the pharmacokinetic patterns and ultimately 
therapeutic success can be obtained through introduction of promoieties with the ideal physiochemical properties.  
Targeted prodrug design represents a new strategy for directed and efficient drug delivery. Particularly, targeting the 
prodrugs to a specific enzyme or a specific membrane transporter, or both, has potential as a selective drug delivery 
system in cancer chemotherapy
(13)
. Hypoxia distinguish tumor cells, especially those solid tumor cells, from normal cells, 
thus presenting new opportunities for selective cancer treatment
(14)
 .  The rationale employed in the design and 
development of hypoxia-selective agents targeting tumor cells is that hypoxia-selective prodrugs are able to release the 
active cytotoxic agents upon reduction under hypoxic conditions, thus minimizing the systemic toxicity .The efficacy of 
cancer chemotherapy is frequently hampered by a low side effects and improve its efficacy and therapeutic index
(15)
  . 
Recently bio reductive prodrugs strategies have been developed to improve this index by selective delivery of highly 
cytotoxic drugs to the tumor cells themselves. A key advance in this approach has been the principle of conversion of a 
specially designed nontoxic prodrug to a cytotoxic drug by an enzymatic addition of one (1e−) or two (2e−) electrons, to 
initiates the formation of reactive species, these enzymes contained within the tumor cells themselves, on the tumor cell 
surface, or in the tumor cell microenvironment e.g. thioredexin1 enzymes
(16)
. In view of these observations, four new 
derivatives of 2,3-Dihydro-1,4 naphthaquinone have been designed, synthesized and characterized    .                               
2. Results and Discussion 
2.1 The chemistry  
 The designated compounds were synthesized according to schemes (1 to 3). A series of intermediates were synthesized 
as precursors of the target compounds by several experimental steps. The intermediates I was synthesized by reacting 
the acetic anhydride with sodium peroxide in dry ether using the method described previously.
(17)
 According scheme 1. 
This afforded diacetyl peroxide I. This adiacetyl peroxide I was reacted with1, 4 naphthaquinone in glacial acetic acid 
(18)
whereupon new intermediate II were obtained.In the following step II allowed to react with hydrogen peroxide
 (19)
 leading 
to the formation of III. The III was allowed to reacted with sulphoric acid
 (20)
 gave IV. Then IV was reacted with N-
bromosuccinamide
(21)
 leading to the formation of V. 
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Scheme 1: The synthesis of intermediates ( I,II, III, IV,V ). 
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Compound A, B and C were obtained from the reaction of V with sodium salt of 5-fluorouracil, triethylamine salt of 6-
mercaptopurine or potassium salt of acetyl cysteine (scheme 2) and the reactions are nucleophilic substitution reaction. 
(22, 
23) 
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Scheme 2: The synthesis of compound A, B and C. 
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      The reaction of V with sodium pyruvate 
(24)
 and then with sodium bromide 
(25)
 lead to formation of compound D 
(scheme 4). 
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Scheme 3: The synthesis of compound D 
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     The chemical structures of these newly synthesized compound were confirmed by IR, ¹H-NMR spectral 
measurements and elemental microanalysis and were in good agreement with the proposed structures.The IR spectra of II 
showed stretchingabsorption bands 2962 and 2920cm
−1
 , attributed to the C-H of methyl group.The stretching absorption 
band of C=O of α-β unsaturated ketone, function appeared in the 1668 and 1658 cm
−1
 region. The bands appearing at 
1668 and 1658 
cm
−1
 were for the C=C of aromatic function. In the IR spectra of III the stretching vibration of epoxy methane were found at 
2995 cm
-1
,Methyl adjacent to epoxy ring at 1402 cm
-1
. The IR spectra of IV indicated the presence stretching vibration 
ofBroad band of   O-H at 3338 cm
-1
. The IR spectra of V showed stretching absorption band of C-Br at 634.However, 
compounds A,B,C and D exhibited IR and ¹H-NMR spectra consistent with their assigned structures, described in details 
in the 
Experimental section.The IR spectrum of compound A displayed the presence of the general characteristic absorption 
bands:NH stretching of 2
o
 amide appeared at 3209 cm
-1
, C=O strong stretching vibration of 2
o 
amide.Compound B 
showed bands at 3427 cm
-1
for NH stretching of secondary amine and at 1589 cm
−1
 for C=N stretching vibration of purine. 
Compound C displayed the NH stretching of 2
o
 amide at 3209 cm
−1
 and carboxyl C=O at 1720.While compound D showed 
C=O strong asymmetric stretching vibration of ester at 1732 cm
−1
.  
     In the ¹H-NMR of compound A, the following peaks appeared: 10.6 (s, 1H, -OH), 8.0(s, 1H, C-H), 7.6-7.9 (m, 4H, Ar-H), 
4.2 (s, 2H, CH2).The compound B showed the following characteristic peaks: 13.2 (d, 1H. NH of purine), 8.6 (d, 1H, CH), 
8.4 (s, 1H, CH). Compound C showed the following characteristic peaks: 12(s, 1H, COOH), 8.3 (d, 1H, NH), 4.7 (q, 1H, 
CH), 1.8 (s, 3H, CH3). While compound D showed the following characteristic peaks: 5.1 (s, 2H, CH2-Br). 
Elemental microanalysis results were within ± 0.5% of the theoretical values and in good agreement with the proposed 
chemical structures. The detailed data for all compounds are given in the experimental section. 
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2.2. Anticancer Activities  
    The in vitro antitumor activities of the newly synthesized compounds (A, B, C and D) were evaluated against Hep-2 
human larynx cancer cell line by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 2-Htetrazolium bromide (MTT) 
(26)
 with 5-FU 
(Tables 1-3). 
Table 1: effects of different concentrations of 5- Fu and compound  A, B, C and D on growth rate of Hep-2 
human larynx cancer cell line after 24 hrs. 
 
Comp. 
IR% At Different Concentration of Compound A and 5-Fu 
 
7.5µM 15 µM 22.5 µM 30 µM 37.5 µM 45 µM 
       A      74     65.4    73.3     67.4     73.4    68 
       B     65.1      70.2    72.1      71.2      68.5    71 
       C     58. 7      61.9     56.5      52.7      55.7    59.1 
       D     58.3      64.1     58.4      62.2      60.7    69.2 
    5-Fu     72.3      67.8     73.6      69.1      74.2     67.9 
 
Table 2: effects of different concentrations of 5- Fu and compound  A, B, C and D on growth rate of Hep-2 
human larynx cancer cell line after 48 hrs. 
 
Comp. 
IR% At Different Concentration of Compound A and 5-Fu 
 
7.5µM 15 µM 22.5 µM 30 µM 37.5 µM 45 µM 
       A      54.7    45.2    51.2    41.9    58.5     50.7   
       B     65.4    54.3    61.8    59.2    64.6     63.7 
       C     53.3    51.1    55.2    50.4    56.5     55.4 
       D     60.3    54.8    55.1    49.3    52.4     54.6 
    5-Fu     55.2    53.1    54.6    57.9     54.5     54.7 
 
Table 2: effects of different concentrations of 5- Fu and compound  A, B, C and D on growth rate of Hep-2 
human larynx cancer cell line after 48 hrs. 
 
Comp. 
IR% At Different Concentration of Compound A and 5-Fu 
 
7.5µM 15 µM 22.5 µM 30 µM 37.5 µM 45 µM 
       A     60.3    62.6    61.1    55.5    54.9    62.8 
       B    65.2    55.6    53.2    61.1    44.2    54.5 
       C    55.9    56.8    52.4    51.7    50.1    49.2 
       D    51.2    53.4    49.6    54.1    52.8     55.6 
    5-Fu    74.3     7.1.2    66.3    59.7    63.6     69.5 
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 According to the results shown in the tables 1 to 3 the synthesized Compounds (A,B, C and D) exhibited markedcytotoxic 
effects against Hep-2 human larynx cancer cell line at six different concentrations and all exposures times which were  
24,48 and 72 hrs. as compared to 5-Fu 
3. Experimental 
3.1. General 
      Melting points were determined in open capillary tubes on a Gallenkamp melting point apparatus and are uncorrected. 
The IR spectra were recorded (in KBr) on a Buck M500 model IR spectrophotometer and the wave numbers are given in 
cm
−1
. The ¹H-NMR spectra were recorded in DMSO-d6 solutions on Perkin Elmer 60 MHz spectrometer at ambient 
temperature. Chemical shifts were recorded in parts per million (ppm) and were referenced to tetramethylsilane. Elemental 
microanalyses were determined on a Carlo-Erba analyzer type 1106. Purity of the synthesized compounds was checked 
by TLC aluminium sheets coated with silica gel 60 F254 (0.2 mm thickness) and by melting points. 1,4naphthaquinone 
and Sodium pyruvate were pushed from BDH, while Fluorouracil , 6-mercaptopurine and acetylcyteine were kind gift from 
Fluka.All solvents and reagent were Analar grade.  
3.2. Chemical Methods 
3.2.1 Synthesis of diacetyl peroxide (I): 
     Acetic anhydride(6gm, 65.01mmole ) and (25 ml) of dry ether were placed in an Erlnmeyer flask placed in an ice 
path, the mixture was stirred until the internal temperature of the flask about 0 C
0
, (2.5 gm,32.05mmole) of sodium 
peroxide was added in one portion .Cold water then added drop wise to the stirred reaction mixture unit all the sodium 
peroxide had been dissolved. The ether layer was separated from water and the water layer was extracted twice with 
ether. The organic layers was combined and washed with 1 % sodium bicarbonate solution, the ether solution was 
separated and dried over magnesium sulphate ,the ether solution was chilled in ice-isopropyl alcohol over- night and 
titrated.Yield: 60% . 
3.2.2 Synthesis of 2-methyl naphthalene-1, 4- dione (compound II) : 
     A suspension of 1,4 naphthaquinone (0.5gm ,3.16 mmole)in 20 ml of glacial acetic acid was heated to about 100 C0 
with stirring, when the solid was dissolved, ethereal solution of compound I (0.3 gm,3.16 mmole,6.6 ml) was added  very 
slowly through a dropping fennel with stem extending nearly to the bottom of the flask .Evolution of carbon dioxide bubbles 
appear soon and the solution changed to yellow colure, the addition was completed after 1 hour, heating continue for 
additional half an hour. The solvent was removed by vacum and the residue dissolved in ether, washed with 1%sodium 
bicarbonate solution. the ether layer was separated ,dried  over anhydrous magnesium sulphate, and the solvent 
evaporated in vacu to give a yellow crystalline powder, which recrystallized from ether-benzene mixture  .Yield: 65%, m.p. 
103–105 °C; IR (v, cm
−1
):2962 and 2920 of C-H symmetric stretching vibration of methyl group, 1668 and 1658 of C=O 
symmetric stretching vibration of α-β unsaturated ketone and 1624, 1587and 1433 ofC=C symmetric stretching vibration of 
aromatic. 
3.2.3 Synthesis of 1-a- methylnaphtho 2, 3boxirene-2, 7(1aH, 7aH)-dione (compound III) : 
     Compound II (1gm, 5.81 m mole) was dissolved in (12ml) of warm Ethanol and left a side while a second  solution of  
anhydrous sodium carbonate(0.25 gm,2.34 mmole) dissolved in 5ml of water and  a cold 30% hydrogen peroxide 
solution(1ml,8.8mmole) was prepared ,and added to the first solution .The yellow color of quinone was disappeared 
immediately .The flask was cooled with shaking in an ice path .(40ml) water was added .A white precipitate was formed 
,filtered and washed with water until the pink color of the filtrate was disappeared, the precipitate dried  and  recrystallized 
from methanol to give compound III.Yield: 91%, m.p. 90–92 °C; IR (v, cm
−1
):2995 of C-H stretching vibration of epoxy 
methane,1701 and 1695 of C=O strong symmetric stretching vibration of α-β unsaturated keton,1593 and 1448 of C=C 
stretching vibration of aromatic,1402 of Methyl adjacent to epoxy ring and 1246 of 8 micron band symmetric stretching of 
epoxy ring. 
3.2.4 Synthesis of 3-methylnaphthalene-2-hydroxy-1, 4- dione (compound IV) : 
      Cold and concentrated sulphoric acid (5 ml) was added slowly to dry compound III (1gm, 5.31 m mole) in flask,  with 
stirring until a deep red homogenous solution was formed, the solution was stirred for 15 minute and then cooled in an ice 
path. Then 20 ml of distilled water was added slowly to the red solution, yellow precipitate was formed, the mixture was 
extracted with 25 ml of each ether and benzene, the organic layer was separated and dried over anhydrous magnesium 
sulphate. The solvent was evaporated to about 10 ml and filtered. The precipitate was collected to give compound 
IV.Yield: 88%, m.p. 170–171 °C; IR (v, cm
−1
):3338 of Broad band of   O-H asymmetric stretching vibration associated, 
2999 of C-H stretching vibration of methyl group,1660 and 1649 of C=O strong symmetric stretching vibration of 
unsaturated keton and 1645,1587and1454 of C=C stretching vibration of aromatic. 
3.2.5 Synthesis of 2-(bromo methyl)-3-hydroxy naphthalene-1,4dione(compound V) : 
     Compound IV (1gm, 5.31 mmole) was dissolved  in  20ml of dry dichloromethane with stirring ,N-bromosuccinamide 
(0.94gm, 5.31 mmole) and a catalytic amount (0.01gm) of  benzoyl peroxide was added in portions, the resulting solution 
was reflexed for 2.5 hours. The solvent was evaporated ,and the residue was dissolved in ether, filtered to remove 
succinamide , the filtrate was evaporated. The residue was triturated with petroleum ether and dried, to give crystals of 
 ISSN 2321-807X 
 
479 | P a g e                                                         O c t  0 6 ,  2 0 1 3 
compound V.Yield: 83%, m.p. 84–86 °C; IR (v, cm
−1
):3373 of Broad absorption band of   O-H asymmetric stretching 
vibration,2991 and 2943 of C-H stretching vibration of methylene, 1691 of C=O strong stretching vibration of α-β 
unsaturated keton and 1645, 1587and1454 of C=C stretching vibration of aromatic. 
3.2.6 Synthesis of 2-((5-fluoro-1, 2-dihydropyrimidin-4-yloxy)methyl)-3-hydroxy naphthalene-
1,4dione(compound A):  
     To stirred suspension of sodium 5-fluorouracil(1gm,6.57mmole) in  20ml of dry acetone, a solution of compound V 
(1.75gm, 6.57mmole) in 10ml of dry acetone was added, the mixture was heated to gentl reflex for 18 hours, then cooled, 
evaporate the solvent and the residue was dissolved in water: ethyl acetate(50:50) mixture(30 ml). The organic layer was 
separated, and the aqueous layer extracted with ethyl acetate, the combined organic layer was dried with magnesium 
sulphate . The solvent was evaporated, to give compound A. Yield: 65%, m.p. 232-233°C. Anal.% calcd. For 
C15H9FN2O5(316.24); C:56.97, H: 2.87, N:8.86;found: C: 57.11, H: 2.89,N:8.89.  IR (v, cm
−1
):  3209 of NH stretching of 2
o
 
amide,2929 and 2833 of CH2 stretching vibration, 1691 of C=O strong stretching vibration of α-β unsaturated keton,1683 
of C=O strong stretching vibration of 2
o 
amide and 1141 and 1645, 1587and1454 of C=C stretching vibration of 
aromatic.¹H-NMR δ (ppm):10.6 (s,1H, -OH), 8.0(s, 1H, C-H), 7.6-7.9 (m, 4H, Ar-H), 4.2 (s, 2H, CH2). 
3.2.6 Synthesisof2-((9H-purin-6-ylthio)-3-hydroxyl naphthalene-1, 4- dione (compound B). 
      6-mercaptopurine mono hydrate(1gm,5.88mmole) was suspended in(20 ml)of D.W .Triethyl amine(0.84ml, 6 mmole 
) was added, and the resulted clear solution was stirred at room temperature for 1o minute ,a solution of compound V(1.57 
gm,5.88 mmole) in 5ml of THF was added slowly with continuous stirring ,after of completion of addition, the solution was 
stirred for 3 hours. and a precipitate was formed, filtered,dried and recrystallized from ethanol-water, to give compound 
B.Yield: 60%, m.p. 214-217 °C (decomposed).Anal. % calcd.ForC16H10N4O3S(338.34);C:56.80, H:2.98, N:16.56, S:9.48; 
found:C: 56.93, H:3.00, N: 16.60, S:9.51. IR (v, cm
−1
):  3427 of NH stretching of secondary amine,3329 of O-H broad 
stretching vibration of hydroxyl group,2924 and 2825 ofC-H stretching vibration of  CH2, 1691 of C=O strong stretching 
vibration of α-β unsaturated keton,1589 of C=N stretching vibration of purine and 678 of C-S stretching vibration . ¹H-NMR 
δ (ppm):13.2 (d, 1H. NH of purine),10.6 (s,1H, -OH),8.6 (d, 1H, CH), 8.4 (s, 1H, CH),7.6-6.9(m, 4H, Ar-H),3.6 (s, 2H, CH2). 
3.2.7 Synthesis of acetmido-3-((3-methyl-1, 4-dihydronaphthalen-2-yl) methylthio) propanoic acid 
(compound C). 
    N-acetylcystine (0.5gm,3.08 m mole) was dissolved in (15ml) of DMF ,and powdered KOH(0.345gm,6.16 mmole) was 
added, and the mixture was stirred at room temperature for 30minute,then compound V(0.82 gm, 3.08 mmole) in 10 ml 
DMF was added slowly with stirring. After completion of addition, the stirring continue for 2 hrs. and acidified with dilute 
HCl to pH 5 then 50 ml of cold D.w was added and the resulting precipitate was extracted by ethyl acetate. The ethyl 
acetate layer was separated and washed with water; the water layer was extracted with ethyl acetate. The combined 
organic layer was dried over anhydrous s magnesium sulphate and evaporated to give compound C. Yield: 65%, m.p. 
140-141°C (decomposed).Anal. % calcd.For C17H17NO5S(347.39); C:58.78, H:4.93, N:4.03, S:9.23; found:C:58.83, 
H:4.94, N:4.07, S:9.28. IR (v, cm
−1
): 3209 for NH stretching of 2
o
 amide,2929 and 2833 forCH2 stretching vibration,2298-
3200 for Broad O-H stretching,  1720 for carboxyl C=O, 1691 of C=O strong stretching vibration of α-β unsaturated keton. 
¹H-NMR δ (ppm):12(s, 1H, COOH),10.6 (s,1H, -OH),8.3 (d, 1H, NH),7.6-6.9(m, 4H, Ar-H),4.7 (q, 1H, CH), 3.11(s, 1H, CH), 
3.00( d, 2H, CH2),1.8 (s, 3H, CH3). ¹H-NMR δ (ppm): 
3.2.8 Synthesis of(3-hydroxy-1,4-dioxo-1,4-dihydrnaphthalen-2-yl)methyl 2-oxopropanoate 
(compound VI) : 
   To a stirred suspension of sodium pyruvate (1gm, 9.09 m mole)  in10ml of DMSO,  a solution of (2.42g, 9.09mmole)of 
compound V in 7 ml of DMSO was added ,and the mixture was stirred at room temperature for 2 hours, then 40 ml of 
cooled water was added. The resulted precipitate was extracted with ethyl acetate, the ethyl acetate layer separated and 
washed with water twice. The combined ethyl acetate layer was dried with magnesium sulphate , and the solvent was 
evaporated, to give compound VI. Yield: 70%, oily material; IR (v, cm
−1
):3404 for O-H stretching vibration of hydroxyl 
group, 2985 and 2850 of C-H stretching vibration of methylene, 1724 for C=O strong symmetric stretching vibration of 
ester, 1691 of C=O strong stretching vibration of α-β unsaturated keton,1589and 1458 for C=C stretching vibration of 
aromatic. 
3.2.9 Synthesis of 3-hydroxy-1, 4-dioxo-1,4-dihydronaphthalen-2-yl)methyl3-bromo-2   
oxopropanoate ( compound D) : 
    To a stirred solution of compound VI (1gm , 3.64mmole) in 12ml of glacial acetic acid at room temperature ,one drop of 
concentrated sulphuric acid was added ,then a solution of bromine (0.56gm,3.64mmole)  in 5ml of glacial acetic acid was 
added drop wise at such a rate in which each drop was added when the yellow color disappeared, the solution then stirred 
at room temperature for 3hours after completion the addition ,the mixture was poured to 50 ml of cold water with stirring, 
extracted with ether. The ether extract washed with1%sodium bicarbonate, dried with anhydrous magnesium sulphate and 
evaporated to give an oil residue of compound D.Yield: 60%, m.p. 65-67°C.Anal.% calcd. For C14H9BrO6 (353.12); 
C:47:62, H:2.57; found:C:47.69, H:2:56.IR (v, cm
−1
):3433 for O-H stretching vibration,2987 and 2854 for CH2 stretching 
vibration,1732 for C=O strong asymmetric stretching vibration of ester,1691 of C=O strong stretching vibration of α-β 
unsaturated keton,1589 and 1458 for C=C stretching vibration of aromatic.¹H-NMR δ (ppm): 10.6 (s,1H, -OH), 8.0(s, 1H, 
C-H), 7.6-7.9 (m, 4H, Ar-H),5.1 (s, 2H, CH2-Br), 4.8(s, 2H, CH2-O-) 
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3.3. Anticancer Activities 
     Cancer cell line utilized in this study was obtained from Biotechnology Center/ Al-Nahrain University, Baghdad, Al-
Jjadriya and was maintained in RPMI-1640 supplemented with 10% FCS.The in vitro antitumor activities of the 
compounds by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 2-Htetrazolium bromide (MTT) method and the data were 
analyzed by 2-way analysis of variance with ANOVA. The data were represented as mean ± SD. The level of significance 
(p <0.05) was used for analysis of variance in all result.  
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